Quarterly report pursuant to Section 13 or 15(d)

Description of Business and Summary of Significant Accounting Policies (Tables)

v3.20.2
Description of Business and Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of cash and cash equivalent and restricted cash
(in thousands)   March 31,
2020		     December 31,
2019		  
Cash and cash equivalents   $ 5,942     $ 9,254  
Restricted cash – current     48       48  
Restricted cash – long-term     391       391  
Cash, cash equivalents and restricted cash   $ 6,381     $ 9,693  
Schedule of antidilutive securities excluded from computation of diluted net loss per share
(in thousands)   March 31,
2020		     March 31,
2019		  
Options     11,061       7,784  
Warrants     86,141       43,473  
Total     97,202       51,257